Urology
Volume 68, Issue 3, Supplement , Pages 47-60, September 2006

Cardiovascular safety of sildenafil citrate (Viagra®): An updated perspective

  • Graham Jackson

      Affiliations

    • St. Thomas Hospital, London, United Kingdom
    • Graham Jackson and Melvin D. Cheitlin are consultants to, and meeting participants and lecturers for, Pfizer Inc.
    • Corresponding Author InformationReprint requests: Graham Jackson, MD, FESC, FRCP, FACC, Cardiology Department, St. Thomas Hospital, Lambeth Palace Road, London SE1 7EH, United Kingdom.
    • ,
  • Piero Montorsi

      Affiliations

    • Institute of Cardiology, University of Milan Centro Cardiologico, Milan, Italy
    • ,
  • Melvin D. Cheitlin

      Affiliations

    • San Francisco General Hospital, San Francisco, California, USA.
    • Graham Jackson and Melvin D. Cheitlin are consultants to, and meeting participants and lecturers for, Pfizer Inc.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.

PII: S0090-4295(06)00891-0

doi:10.1016/j.urology.2006.05.047

Urology
Volume 68, Issue 3, Supplement , Pages 47-60, September 2006

Article Tools

* Image Usage & Resolution